Cargando…
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer
SIMPLE SUMMARY: CDK4/6 inhibitors target cell proliferation resulting in toxicity, mainly bone marrow suppression manifesting as neutropenia. Radiation therapy (RT), widely used in breast cancer patients, may enhance myelotoxicity, and no consensus guidelines exist to guide practice when both treatm...
Autores principales: | Kubeczko, Marcin, Gabryś, Dorota, Gawkowska, Marzena, Polakiewicz-Gilowska, Anna, Cortez, Alexander J., Krzywon, Aleksandra, Woźniak, Grzegorz, Latusek, Tomasz, Leśniak, Aleksandra, Świderska, Katarzyna, Mianowska-Malec, Marta, Łanoszka, Barbara, Chomik, Konstanty, Gajek, Mateusz, Michalik, Anna, Nowicka, Elżbieta, Tarnawski, Rafał, Rutkowski, Tomasz, Jarząb, Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913652/ https://www.ncbi.nlm.nih.gov/pubmed/36765648 http://dx.doi.org/10.3390/cancers15030690 |
Ejemplares similares
-
Efficacy of CDK 4/6 Inhibitors and Radiotherapy in Breast Cancer Patients with Brain Metastases
por: Kubeczko, Marcin, et al.
Publicado: (2023) -
Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
por: Grzbiela, Hanna, et al.
Publicado: (2023) -
Chemotherapy for gastric cancer patients – time for personalization in medicine?
por: Nowara, Elżbieta, et al.
Publicado: (2012) -
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020) -
Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2020)